Call Today: 310-423-9640

When it was approved in 2003 as the first new laser in five years, the FDA granted ALLEGRETTO WAVE® the widest approval range ever initially given to a
new laser for both myopic and hyperopic vision correction. Since then, the results have been astoundingly positive. ALLEGRETTO WAVE® has been proven to provide superior clinical results, as shown by the following statistics:

A great source for information about LASIK and questions to ask your physician is the FDA website and the website of the American Society of Cataract and Refractive Surgery.

ALLEGRETTO WAVE® expands the boundaries of candidacy for LASIK. However, there are certain people who are less than ideal candidates for LASIK and ALLEGRETTO WAVE®. These patients are encouraged to speak with their doctor to find the best vision correction option:

LASIK is also not recommended for patients with:

During the consultation with your doctor, please be sure to mention all medications you are taking and any medical conditions you have that might affect the success of laser correction.

Click below to view the PDF of the complete ALLEGRETTO WAVE® clinical results for Myopia and Hyperopia.

For information regarding the risks and benefits associated with the ALLEGRETTO WAVE® treatment, please visit www.allegrettowave.com or www.fda.gov.

Back to top